These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6209320)

  • 41. Pathogenic autoantibodies.
    Bach JF
    Contrib Microbiol Immunol; 1989; 11():263-88. PubMed ID: 2684511
    [No Abstract]   [Full Text] [Related]  

  • 42. Autoimmunity in immunopathology.
    Carpenter AB; Rabin BS
    Clin Lab Med; 1983 Dec; 3(4):745-62. PubMed ID: 6360505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmune endocrine diseases.
    De Baets MH
    Year Immunol; 1986; 2():289-302. PubMed ID: 3554825
    [No Abstract]   [Full Text] [Related]  

  • 44. Complicating autoimmune diseases in myasthenia gravis: a review.
    Nacu A; Andersen JB; Lisnic V; Owe JF; Gilhus NE
    Autoimmunity; 2015; 48(6):362-8. PubMed ID: 25915571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
    Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
    Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
    [No Abstract]   [Full Text] [Related]  

  • 46. Complement-mediated muscle damage produced by myasthenic sera.
    Childs LA; Harrison R; Lunt GG
    Ann N Y Acad Sci; 1987; 505():180-93. PubMed ID: 3479926
    [No Abstract]   [Full Text] [Related]  

  • 47. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.
    Minich WB; Lenzner C; Morgenthaler NG
    Clin Exp Immunol; 2004 Apr; 136(1):129-36. PubMed ID: 15030524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.
    Howard FM; Lennon VA; Finley J; Matsumoto J; Elveback LR
    Ann N Y Acad Sci; 1987; 505():526-38. PubMed ID: 3479935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical features of patients with myasthenia gravis associated with autoimmune diseases.
    Kanazawa M; Shimohata T; Tanaka K; Nishizawa M
    Eur J Neurol; 2007 Dec; 14(12):1403-4. PubMed ID: 17941854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis.
    Oger JJ
    Ann N Y Acad Sci; 1993 Jun; 681():110-2. PubMed ID: 8357159
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anti-TSH receptor antibodies and autoimmune thyroid diseases].
    Ichikawa Y; Arikawa K; Yoshida T; Suzuki Y; Kawai S
    Horumon To Rinsho; 1983 Dec; 31(12):1185-90. PubMed ID: 6323060
    [No Abstract]   [Full Text] [Related]  

  • 54. [Stimulating autoantibodies against hormone receptors and some receptor diseases].
    Zhao T; Lin SX; Li P
    Sheng Li Ke Xue Jin Zhan; 1983 Jan; 14(1):19-24. PubMed ID: 6304872
    [No Abstract]   [Full Text] [Related]  

  • 55. Graves' disease as a model for anti-Gal involvement in autoimmune diseases.
    Galili U
    Subcell Biochem; 1999; 32():339-60. PubMed ID: 10392002
    [No Abstract]   [Full Text] [Related]  

  • 56. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial occurrence of autoimmune myasthenia gravis with different antibody specificity.
    Lavrnic D; Nikolic A; De Baets M; Verschuuren J; Verduyn W; Losen M; Stojanovic V; Stevic Z; Hajdukovic Lj; Apostolski S
    Neurology; 2008 May; 70(21):2011-3. PubMed ID: 18490624
    [No Abstract]   [Full Text] [Related]  

  • 58. Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease.
    Kohn LD; Alvarez F; Marcocci C; Kohn AD; Corda D; Hoffman WE; Tombaccini D; Valente WA; de Luca M; Santisteban P
    Ann N Y Acad Sci; 1986; 475():157-73. PubMed ID: 3491561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myasthenia gravis and autoimmunity.
    Whitaker JN
    Adv Intern Med; 1980; 26():489-510. PubMed ID: 6164271
    [No Abstract]   [Full Text] [Related]  

  • 60. Autoimmune thyroid disease: developments in our understanding.
    Weetman AP; McGregor AM
    Endocr Rev; 1984; 5(2):309-55. PubMed ID: 6329669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.